Fulminant hepatitis B

Fulminant hepatitis, or fulminant hepatic failure, is defined as a clinical syndrome of severe liver function impairment, which causes hepatic coma and the decrease in synthesizing capacity of liver, and develops within eight weeks of the onset of hepatitis. Several independent factors influence the...

Full description

Saved in:
Bibliographic Details
Main Authors: Đokić Milomir, Begović Vesna, Rajić-Dimitrijević Radmila, Aleksić Rada, Popović Svetlana, Hristović Dejan
Format: Article
Language:English
Published: Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2003-01-01
Series:Vojnosanitetski Pregled
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2003/0042-84500303353D.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850230035251724288
author Đokić Milomir
Begović Vesna
Rajić-Dimitrijević Radmila
Aleksić Rada
Popović Svetlana
Hristović Dejan
author_facet Đokić Milomir
Begović Vesna
Rajić-Dimitrijević Radmila
Aleksić Rada
Popović Svetlana
Hristović Dejan
author_sort Đokić Milomir
collection DOAJ
description Fulminant hepatitis, or fulminant hepatic failure, is defined as a clinical syndrome of severe liver function impairment, which causes hepatic coma and the decrease in synthesizing capacity of liver, and develops within eight weeks of the onset of hepatitis. Several independent factors influence the survival of patients: age, the cause of liver disease, the degree and the duration of encephalopathy in relation to the onset of the disease, and the prevention of complications. Over the years many intensive treatments have been practiced. Liver transplantation is expensive, and patients who survive transplantation require life-long immunosupression, clinical care and complications management. Without transplantation fulminant hepatitis and hepatic failure might be completely recovered spontaneously, and the patient could expect a normal life. Two cases of fulminant B hepatitis with intensive care treatment, and their survival despite unfavorable prognosis are presented in this paper. The menagement of patients with fulminant hepatitis required intensive monitoring and therapeutic measures, including corticosteroids. The prognosis for survival without transplantation in fulminant hepatitis is limited by the measures of medical treatment and new specific therapeutic modalities which must be developed through basic research.
format Article
id doaj-art-d72bb9f1ab4e440285082d6aa5fdfc32
institution OA Journals
issn 0042-8450
language English
publishDate 2003-01-01
publisher Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade
record_format Article
series Vojnosanitetski Pregled
spelling doaj-art-d72bb9f1ab4e440285082d6aa5fdfc322025-08-20T02:04:00ZengMinistry of Defence of the Republic of Serbia, University of Defence, BelgradeVojnosanitetski Pregled0042-84502003-01-0160335336010.2298/VSP0303353DFulminant hepatitis BĐokić MilomirBegović VesnaRajić-Dimitrijević RadmilaAleksić RadaPopović SvetlanaHristović DejanFulminant hepatitis, or fulminant hepatic failure, is defined as a clinical syndrome of severe liver function impairment, which causes hepatic coma and the decrease in synthesizing capacity of liver, and develops within eight weeks of the onset of hepatitis. Several independent factors influence the survival of patients: age, the cause of liver disease, the degree and the duration of encephalopathy in relation to the onset of the disease, and the prevention of complications. Over the years many intensive treatments have been practiced. Liver transplantation is expensive, and patients who survive transplantation require life-long immunosupression, clinical care and complications management. Without transplantation fulminant hepatitis and hepatic failure might be completely recovered spontaneously, and the patient could expect a normal life. Two cases of fulminant B hepatitis with intensive care treatment, and their survival despite unfavorable prognosis are presented in this paper. The menagement of patients with fulminant hepatitis required intensive monitoring and therapeutic measures, including corticosteroids. The prognosis for survival without transplantation in fulminant hepatitis is limited by the measures of medical treatment and new specific therapeutic modalities which must be developed through basic research.http://www.doiserbia.nb.rs/img/doi/0042-8450/2003/0042-84500303353D.pdfliver failureacutehepatitis Bhepatic encephalopathyclinical chemistry testadrenal cortex hormonesglucocorticosteroidsprognosis
spellingShingle Đokić Milomir
Begović Vesna
Rajić-Dimitrijević Radmila
Aleksić Rada
Popović Svetlana
Hristović Dejan
Fulminant hepatitis B
Vojnosanitetski Pregled
liver failure
acute
hepatitis B
hepatic encephalopathy
clinical chemistry test
adrenal cortex hormones
glucocorticosteroids
prognosis
title Fulminant hepatitis B
title_full Fulminant hepatitis B
title_fullStr Fulminant hepatitis B
title_full_unstemmed Fulminant hepatitis B
title_short Fulminant hepatitis B
title_sort fulminant hepatitis b
topic liver failure
acute
hepatitis B
hepatic encephalopathy
clinical chemistry test
adrenal cortex hormones
glucocorticosteroids
prognosis
url http://www.doiserbia.nb.rs/img/doi/0042-8450/2003/0042-84500303353D.pdf
work_keys_str_mv AT đokicmilomir fulminanthepatitisb
AT begovicvesna fulminanthepatitisb
AT rajicdimitrijevicradmila fulminanthepatitisb
AT aleksicrada fulminanthepatitisb
AT popovicsvetlana fulminanthepatitisb
AT hristovicdejan fulminanthepatitisb